Skip to search.
 FTSE 100 Down 0.30%

Achillion Pharmaceuticals, Inc. (ACHN)

-NasdaqGS
8.42 Down 0.18(2.09%) 25 Jul 21:00
Prev Close:8.60
Open:8.58
Bid:7.20 x 500
Ask:8.81 x 1900
1y Target Est:9.14
Beta:1.99564
Next Earnings Date: 4-Aug-16ACHN Earnings announcement
Day's Range:8.33 - 8.59
52wk Range:5.57 - 10.95
Volume:857,101
Avg Vol (3m):1,395,700
Market Cap:1.15b
P/E (ttm):N/A
EPS (ttm):-0.03
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for ACHN at this time.

Comparison

Symbol% ChgMkt Cap
ACHNDown 2.09%1.15b
GSKUp 0.36%106.97b
JNJDown 0.11%343.53b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):17.77
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.64
Quarterly EPS Est (Jun-16) :-0.15
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):-0.76

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes small molecule drug therapies for infectious diseases and immune system disorders in the United States and internationally. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback